barium and fluoxetine
barium has been researched along with fluoxetine in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gean, PW; Lu, KT | 1 |
| Choi, JS; Hahn, SJ; Jo, YH; Kim, MS; Oh, CS; Rhie, DJ | 1 |
| Bányász, T; Harasztosi, C; Kecskeméti, V; Körtvély, A; Kovács, L; Magyar, J; Nánási, PP; Pacher, P; Pankucsi, C; Rusznák, Z; Szûcs, G | 1 |
| Harasztosi, C; Kecskeméti, V; Nánási, PP; Pál, B; Riba, P; Rusznák, Z; Szûcs, G; Wagner, R | 1 |
| Caricati-Neto, A; Jurkiewicz, A; Jurkiewicz, NH; Pereira, JD | 1 |
Other Studies
5 other study(ies) available for barium and fluoxetine
| Article | Year |
|---|---|
Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Barium; Epilepsy; Excitatory Postsynaptic Potentials; Fluoxetine; Hippocampus; In Vitro Techniques; Ketanserin; Male; Membrane Potentials; Metergoline; Neurons; Oxadiazoles; Picrotoxin; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission; Tryptamines | 1998 |
Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Barium; Calcium Channels; Cyclic AMP; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Fluoxetine; Guanosine Diphosphate; Ion Channels; Membrane Potentials; Patch-Clamp Techniques; PC12 Cells; Pertussis Toxin; Potassium Channels; Protein Kinase C; Protein Kinase Inhibitors; Rats; Selective Serotonin Reuptake Inhibitors; Sodium Channels; Thionucleotides; Virulence Factors, Bordetella | 1999 |
Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues.
Topics: Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Barium; Calcium; Calcium Channels; Dogs; Fluoxetine; Myocytes, Cardiac; Neurons; Rats; Selective Serotonin Reuptake Inhibitors | 2003 |
Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.
Topics: Animals; Anticonvulsants; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cells, Cultured; Clonazepam; Cochlear Nucleus; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Fluoxetine; Male; Membrane Potentials; Mice; Neurons, Afferent; Patch-Clamp Techniques; Phenytoin; Selective Serotonin Reuptake Inhibitors | 2005 |
Decreased noradrenergic and serotonergic reactivity of vas deferens of newborn rats from mothers treated with the serotonin reuptake inhibitor fluoxetine during pregnancy and breast-feeding.
Topics: Animals; Animals, Newborn; Barium; Birth Weight; Calcium; Dose-Response Relationship, Drug; Electric Stimulation; Female; Fluoxetine; Growth; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Vas Deferens | 2007 |